The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the association between clonal hematopoiesis and germline pathogenic and likely pathogenic variants in cancer predisposition genes.
 
Elizabeth Anne Comen
Employment - Survivornet
Stock and Other Ownership Interests - Survivornet
Honoraria - ClearView Healthcare Partners; Decision Resources; Gerson Lehrman Group; Grey Global Group; Kantar Health; Kantar Health; Navigant Consulting; Pfizer; Pfizer; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; HERON; Novartis; Pfizer
Research Funding - Roche
Travel, Accommodations, Expenses - Novartis; Pfizer; Pfizer
 
Pedram Razavi
Consulting or Advisory Role - AstraZeneca; Foundation Medicine; Novartis
Research Funding - GRAIL (Inst); Illumina (Inst)
Travel, Accommodations, Expenses - Epic Sciences; Guardant Health
 
Parth Bhargav Patel
No Relationships to Disclose
 
Axel Martin
No Relationships to Disclose
 
Venkatraman E. Seshan
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Ryan Ptashkin
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Alimera Sciences (I); Allergan (I); Biomarin (I); Fortress Biotech (I); Genentech/Roche (I); Novartis (I); Optos (I); Regeneron (I); Regenxbio (I); Spark Therapeutics (I)
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck (I); NCCN/AstraZeneca; Takeda
Research Funding - Helsinn Therapeutics; Loxo (Inst)
 
Michael F. Berger
Consulting or Advisory Role - Roche
Research Funding - Grail
 
Ahmet Zehir
Honoraria - Illumina
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - Change HealthCare
Research Funding - Abbvie (Inst); AstraZeneca (Inst); InVitae (Inst); Medivation (Inst); Myriad Genetics (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
Other Relationship - Clinical Care Options; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo; Merck; Pfizer
 
Jorge S. Reis-Filho
Consulting or Advisory Role - Genentech/Roche; Goldman Sachs; Invicro; Novartis; Paige.AI; Repare Therapeutics; Ventana Medical Systems; Volition RX
 
Larry Norton
Honoraria - Advanced Breast Cancer International Consensus Conference; ASCO; Bluprint Oncology Concepts; Breast Cancer Research Program; Cancer Moonshot; Celgene; Context Therapeutics; MCI Breast Cancer Symposium; Oncology Pioneers; Prime Oncology; Sarah Lawrence College; Sermonix Pharmaceuticals
Consulting or Advisory Role - Advanced Breast Cancer International Consensus Conference; ASCO; Bluprint Oncology Concepts; Breast Cancer Research Program; Cancer Moonshot; Context Therapeutics; Hackensack University Medical Center; Martell diagnostic; MCI Breast Cancer Symposium; Oncology Pioneers; Prime Oncology; Sarah Lawrence College; Sermonix Pharmaceuticals
Travel, Accommodations, Expenses - Advanced Breast Cancer International Consensus Conference; BIG-NABCG; Breast Cancer Research Program; Celgene; MCI Breast Cancer Symposium; Oncology Pioneers; Pfizer; Samus Therapeutics; University of California, San Francisco
 
Ross L. Levine
Leadership - Qiagen
Stock and Other Ownership Interests - C4 Therapeutics; Imago Pharma; IsoPlexis; Loxo; Qiagen
Honoraria - Amgen; Lilly
Consulting or Advisory Role - C4 Therapeutics; Celgene; Imago Pharma; IsoPlexis; Loxo; Prelude Therapeutics; Roche
Speakers' Bureau - Amgen; Lilly
Research Funding - Celgene; Prelude Therapeutics; Roche
Travel, Accommodations, Expenses - Auron Therapeutics; C4 Therapeutics; Constellation Pharmaceuticals; Genome; Incyte; Qiagen